Eli Lilly and Company: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-07-05
Other years: 2026 vs 2025
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

0
New Risks
0
Removed
9
Modified
7
Unchanged
🟡 Modified •Regulatory compliance problems could be damaging to the company. 🔒
🟡 Modified •Reliance on third-party relationships and outsourcing arrangements could adversely affect our business. 🔒
🟡 Modified •Uneven economic growth or downturns or international trade and other global disruptions, geopolitical tensions, or disputes could adversely affect our business and operating results. 🔒
🟡 Modified •Manufacturing, quality, or supply chain difficulties, disruptions, or shortages could lead to product supply problems. 🔒
🟡 Modified •We and our products face intense competition, including from multinational pharmaceutical companies, biotechnology companies, and lower-cost generic and biosimilar manufacturers, and such competition could have a material adverse effect on our business. 🔒
🟡 Modified •Our long-term success depends on intellectual property protection; if our intellectual property rights are invalidated, circumvented, or weakened, our business will be adversely affected. 🔒
🟡 Modified •We derive a significant percentage of our total revenue from relatively few products and sell our products through consolidated supply chain entities, which subjects us to various risks. 🔒
🟡 Modified •Changes in foreign currency rates, interest rate risks, and inflation or deflation affect our results of operations. 🔒
🟡 Modified •We are party to litigation and investigations related to our products, how we price or commercialize our products, and other aspects of our business, which could adversely affect our business, and we are self-insured for such matters. 🔒
9 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →